Quantitative Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-45,189
| Closed | -$1.13M | – | 515 |
|
|
2025
Q4 | $1.13M | Buy |
45,189
+17,662
| +64% | +$445K | 0.11% | 192 |
|
|
2025
Q3 | $701K | Sell |
27,527
-57,656
| -68% | -$1.42M | 0.1% | 181 |
|
|
2025
Q2 | $2.06M | Buy |
+85,183
| New | +$1.99M | 0.28% | 76 |
|
|
2025
Q1 | – | Sell |
-241,677
| Closed | -$6.41M | – | 448 |
|
|
2024
Q4 | $6.41M | Buy |
+241,677
| New | +$6.56M | 0.48% | 47 |
|
|
2024
Q3 | – | Sell |
-80,150
| Closed | -$2.24M | – | 410 |
|
|
2024
Q2 | $2.24M | Sell |
80,150
-573,592
| -88% | -$15.8M | 0.24% | 83 |
|
|
2024
Q1 | $18.1M | Buy |
653,742
+87,813
| +16% | +$2.44M | 1.07% | 11 |
|
|
2023
Q4 | $16.3M | Buy |
+565,929
| New | +$17.1M | 0.94% | 25 |
|
|
2023
Q2 | – | Sell |
-445,769
| Closed | -$18.2M | – | 338 |
|
|
2023
Q1 | $18.2M | Buy |
+445,769
| New | +$19.3M | 3.83% | 1 |
|
|
2021
Q4 | – | Sell |
-857,241
| Closed | -$36.9M | – | 407 |
|
|
2021
Q3 | $36.9M | Buy |
857,241
+597,297
| +230% | +$26.5M | 3.34% | 3 |
|
|
2021
Q2 | $10.2M | Buy |
259,944
+237,235
| +1,045% | +$9.23M | 0.92% | 27 |
|
|
2021
Q1 | $822K | Sell |
22,709
-9,316
| -29% | -$331K | 0.07% | 257 |
|
|
2020
Q4 | $1.18M | Sell |
32,025
-652,111
| -95% | -$23.9M | 0.1% | 225 |
|
|
2020
Q3 | $23.8M | Sell |
684,136
-395,849
| -37% | -$13.9M | 2.07% | 7 |
|
|
2020
Q2 | $33.5M | Buy |
1,079,985
+677,934
| +169% | +$23M | 3.44% | 4 |
|
|
2020
Q1 | $12.4M | Buy |
+402,051
| New | +$13.7M | 1.36% | 12 |
|
|
2019
Q3 | – | Sell |
-456,708
| Closed | -$18.8M | – | 736 |
|
|
2019
Q2 | $18.8M | Buy |
456,708
+36,267
| +9% | +$1.44M | 0.73% | 26 |
|
|
2019
Q1 | $16.9M | Buy |
+420,441
| New | +$16.8M | 0.98% | 11 |
|
|
2018
Q3 | – | Sell |
-473,562
| Closed | -$16.3M | – | 819 |
|
|
2018
Q2 | $16.3M | Buy |
473,562
+148,930
| +46% | +$5.09M | 0.34% | 56 |
|
|
2018
Q1 | $10.9M | Sell |
324,632
-77,785
| -19% | -$2.67M | 0.19% | 126 |
|
|
2017
Q4 | $13.8M | Sell |
402,417
-1,031,761
| -72% | -$35.2M | 0.2% | 114 |
|
|
2017
Q3 | $48.6M | Buy |
1,434,178
+1,235,394
| +621% | +$39.7M | 0.55% | 28 |
|
|
2017
Q2 | $6.33M | Sell |
198,784
-629,976
| -76% | -$19.9M | 0.1% | 273 |
|
|
2017
Q1 | $26.9M | Buy |
+828,760
| New | +$26.1M | 0.41% | 45 |
|
|
2016
Q4 | – | Sell |
-1,448,512
| Closed | -$46.5M | – | 915 |
|
|
2016
Q3 | $46.5M | Buy |
1,448,512
+172,750
| +14% | +$5.78M | 1.54% | 9 |
|
|
2016
Q2 | $42.6M | Buy |
+1,275,762
| New | +$40.7M | 1.99% | 2 |
|
|
2015
Q2 | – | Sell |
-83,688
| Closed | -$2.76M | – | 637 |
|
|
2015
Q1 | $2.76M | Sell |
83,688
-207,954
| -71% | -$6.61M | 0.27% | 72 |
|
|
2014
Q4 | $8.62M | Buy |
+291,642
| New | +$8.36M | 1.33% | 9 |
|
|
2014
Q3 | – | Sell |
-70,618
| Closed | -$1.99M | – | 466 |
|
|
2014
Q2 | $1.99M | Sell |
70,618
-309,138
| -81% | -$8.81M | 0.36% | 54 |
|
|
2014
Q1 | $11.6M | Buy |
379,756
+117,099
| +45% | +$3.49M | 0.55% | 31 |
|
|
2013
Q4 | $7.63M | Buy |
262,657
+221,129
| +532% | +$6.44M | 0.74% | 22 |
|
|
2013
Q3 | $1.13M | Sell |
41,528
-212,381
| -84% | -$5.78M | 0.1% | 192 |
|
|
2013
Q2 | $6.75M | Buy |
+253,909
| New | +$7.02M | 1.19% | 11 |
|
Other funds holding PFE
Quantitative Investment Management's PFE Position: Q1 2026 in Review
Quantitative Investment Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 45,189 shares — an estimated $1.13M sold.
Quantitative Investment Management first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $48.6M in Q3 2017. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Quantitative Investment Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Quantitative Investment Management sold 45,189 Pfizer shares in Q1 2026, an estimated $1.13M.
- Quantitative Investment Management first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Quantitative Investment Management's Pfizer position peaked at $48.6M in Q3 2017.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.